Page 34 - Aet News Today

Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.

There are three key trends for the healthcare industry to follow in 2024, including the rise of AI, increasing cost pressures and M&A activity, according to West Monroe.

Galapagos is a latecomer to CAR T-therapy, but the drugmaker hopes its technology for producing cell therapies at a clinical site will help it stand out. Galapagos has encouraging preliminary data from two early-stage programs and it just begun Phase 1/2 testing of its third cancer cell therapy.

It’s time to transform how government health agencies, pharmaceutical companies, hospitals and other health organizations create and deliver information to the approximately 20 million members of LGBTQ+ communities. Start with paying attention to their "chosen circles" or their trusted sources of information.

At RSNA, three major trends stood out: the integration of artificial intelligence (AI), a renewed focus on health equity, and a dedicated effort to enhance the patient experience.

About 45% of patients have missed or forgotten to pay medical bills because of challenges they experienced in communicating with their provider, a survey from Artera found. Another 43% of patients said that these communication issues negatively affected their health.

While the urgency to fill positions might tempt senior care centers to prioritize quantity over quality, this approach risks exacerbating the existing challenges. It is crucial to acknowledge that the senior care industry demands a level of expertise and empathy that goes beyond mere technical competence.

Health systems have made dozens of M&A deals this year, as many are seeking out partnerships to grow and protect their long-term financial sustainability. Here is a rundown of five newsworthy deals announced in 2023.

The FDA said promethazine hydrochloride, a generic drug used to manage allergies and motion sickness, should be administered by intramuscular injection. Intravenous injection can cause chemical irritation and tissue damage, an FDA alert states.

A new KFF report analyzed recent trends in Medicaid outpatient prescription drug utilization and spending. It discovered that although there's been lower utilization of prescription drugs in recent years, Medicaid spending on prescription drugs has increased.